CIK 0001672619 · Non-accelerated filer
Enliven Therapeutics, Inc.
Sign in to watch- Ticker
- ELVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811523849
- Phone
- 650-547-5814
- Business address
- 205 PARK ROAD, BURLINGAME, CA, 94010
- Former names
- IMARA Inc.
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 144 Insider Sale of Securities
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 6,018 shares at an average $52.64 ($316,780)
- 4 Planned sale CHIEF MEDICAL OFFICER sold 5,000 shares at an average $52.67 ($263,373)
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 10,000 shares at an average $50.49 ($504,903)
- 4 Open-market sale 10% owner sold 860,123 shares at an average $45.36 ($39,014,046)
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 6,018 shares at an average $43.80 ($263,577)
- 4 Planned sale CHIEF MEDICAL OFFICER sold 5,000 shares at an average $43.80 ($219,017)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Open-market sale 10% owner sold 281,408 shares at $45.02 ($12,668,988)
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
Page 2 of 40 · 798 filings